Clinical Trial Update: Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms

View source ↗

Summary

This completed clinical trial investigated risk factors and pathophysiological mechanisms for persistent pain after breast cancer treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema
• Neuropathic Pain
• Pain
• Peripheral Neuropathy

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Breast Cancer, Persistent Pain | Status: COMPLETED